Carlos G Ramos Becerra (Carlos Ramos-Becerra)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Antiretroviral Therapy

Ejection Fraction

Top Venues

Journal of cardiovascular development and disease

This page only lists publications with an associated author ORCID identifier.

Publications

Luis Ricardo Balleza Alejandri, Fernando Grover Páez, Erick González Campos, Carlos G Ramos Becerra, Ernesto Germán Cardona Muñóz, Sara Pascoe González, María Guadalupe Ramos Zavala, Africa Samantha Reynoso Roa, Daniel O Suarez Rico, Alberto Beltrán Ramírez, Jesús Jonathan García Galindo, David Cardona Müller, Claudia Yanette Galán Ruíz
Empagliflozin and Dapagliflozin Improve Endothelial Function in Mexican Patients with Type 2 Diabetes Mellitus: A Double-Blind Clinical Trial. Journal of cardiovascular development and disease 11 (6) (2024)
Luis Ricardo Balleza Alejandri, Fernando Grover Páez, Erick González Campos, Carlos G Ramos Becerra, Ernesto Germán Cardona Muñóz, Sara Pascoe González, María Guadalupe Ramos Zavala, Africa Samantha Reynoso Roa, Daniel O Suarez Rico, Alberto Beltrán Ramírez, Jesús Jonathan García Galindo, David Cardona Müller, Claudia Yanette Galán Ruíz
Empagliflozin and Dapagliflozin Improve Endothelial Function in Mexican Patients with Type 2 Diabetes Mellitus: A Double-Blind Clinical Trial. Journal of cardiovascular development and disease 11 (6) (2024)
Luis Ricardo Balleza Alejandri, Fernando Grover Páez, Erick González Campos, Carlos G Ramos Becerra, Ernesto Germán Cardona Muñóz, Sara Pascoe González, María Guadalupe Ramos Zavala, Africa Samantha Reynoso Roa, Daniel O Suarez Rico, Alberto Beltrán Ramírez, Jesús Jonathan García Galindo, David Cardona Müller, Claudia Yanette Galán Ruíz
Empagliflozin and Dapagliflozin Improve Endothelial Function in Mexican Patients with Type 2 Diabetes Mellitus: A Double-Blind Clinical Trial. Journal of cardiovascular development and disease 11 (6) (2024)
Pedro Martínez-Ayala, Guillermo Adrian Alanis-Sánchez, Monserrat Álvarez-Zavala, Karina Sánchez-Reyes, Vida Verónica Ruiz-Herrera, Rodolfo Ismael Cabrera-Silva, Luz Alicia González-Hernández, Carlos G Ramos Becerra, Ernesto Cardona-Muñoz, Jaime Federico Andrade-Villanueva
Effect of antiretroviral therapy on decreasing arterial stiffness, metabolic profile, vascular and systemic inflammatory cytokines in treatment-naïve HIV: A one-year prospective study. PloS one 18 (3) (2023)
Pedro Martínez-Ayala, Guillermo Adrian Alanis-Sánchez, Monserrat Álvarez-Zavala, Karina Sánchez-Reyes, Vida Verónica Ruiz-Herrera, Rodolfo Ismael Cabrera-Silva, Luz Alicia González-Hernández, Carlos G Ramos Becerra, Ernesto Cardona-Muñoz, Jaime Federico Andrade-Villanueva
Effect of antiretroviral therapy on decreasing arterial stiffness, metabolic profile, vascular and systemic inflammatory cytokines in treatment-naïve HIV: A one-year prospective study. PloS one 18 (3) (2023)
Pedro Martínez-Ayala, Guillermo Adrian Alanis-Sánchez, Monserrat Álvarez-Zavala, Karina Sánchez-Reyes, Vida Verónica Ruiz-Herrera, Rodolfo Ismael Cabrera-Silva, Luz Alicia González-Hernández, Carlos G Ramos Becerra, Ernesto Cardona-Muñoz, Jaime Federico Andrade-Villanueva
Effect of antiretroviral therapy on decreasing arterial stiffness, metabolic profile, vascular and systemic inflammatory cytokines in treatment-naïve HIV: A one-year prospective study. PloS one 18 (3) (2023)
Pedro Martínez-Ayala, Guillermo Adrian Alanis-Sánchez, Monserrat Álvarez-Zavala, Karina Sánchez-Reyes, Vida Verónica Ruiz-Herrera, Rodolfo Ismael Cabrera-Silva, Luz Alicia González-Hernández, Carlos G Ramos Becerra, Ernesto Cardona-Muñoz, Jaime Federico Andrade-Villanueva
Effect of antiretroviral therapy on decreasing arterial stiffness, metabolic profile, vascular and systemic inflammatory cytokines in treatment-naïve HIV: A one-year prospective study. PloS one 18 (3) (2023)